Announcements Trials
Browse Landscape

Status

Recruiting 13Active not recruiting 3Completed 2Withdrawn 1No longer available 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Epidermal Growth Factor Receptor (EGFR)-Mutated Non Small Cell Lung Cancer 1

Interventions

Suspensions 2Powders 2trametinib 1talquetamab 1taletrectinib 1sotorasib 1ruxolitinib 1revumenib 1patritumab deruxtecan 1omburtamab I-131 1leronlimab 1gallium maltolate 1dabrafenib 1ceritinib 1capmatinib 1asparaginase erwinia chrysanthemi recombinant 1apalutamide 1Standard of Care 1Paclitaxel 1Nivolumab 1HMPL-013 1Docetaxel 1Asparaginase 1Androgen Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
No longer available × patritumab deruxtecan × 1 year × Clear all
NCT06099639 2025-06-08

Medical Access Program for Patritumab Deruxtecan

Daiichi Sankyo

No longer available
Thoracic

Epidermal Growth Factor Receptor (EGFR)-Mutated Non Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡